THE CONTENT OF LINOLEIC AND ALPHA-LINOLENIC ACID IN DIFFERENT TYPES OF YERBA MATE, DEPENDING ON COUNTRY OF ORIGIN AND THE CONDITIONS OF THE INFUSION

Dominika Maciejewska, Agnieszka Łukomska, Karolina Jakubczyk, Irena Baranowska-Bosiacka, Ewa Stachowska, Dariusz Chlubek, Izabela Gutowska

Abstract


Introduction: Yerba Mate (Ilex paraguariensis) is one of the most widely consumed teas in South America. It is becoming more and more popular in North America and Europe. The aim of the study was a qualitative and quantitative analysis of the fatty acids from the omega 6 and omega 3 families in Yerba Mate teas.

Methods: There were two types of infusions – cold and hot (three brews from the same leaves). Yerba Mate was incubated for 10 min, then 2 mL of the brew was taken for isolation. Fatty acids were extracted by the Folch method. The resulting fatty acid methyl esters were analyzed using gas chromatography.

Results: The analysis of fatty acids in the infusions of Yerba Mate showed a significant amount of linoleic acid (LA) and alpha-linolenic acids (ALA). The concentrations of these acids present in fresh infusions were approx. 250 ug/mL for infusion of LA, and 600 ug/mL infusion for ALA. With the subsequent brew using the same leaves the amount of fatty acids decreased significantly (p < 0.01).

Conclusions: Drinking Yerba Mate can supply ALA and LA, which are essential in a well-balanced diet. For individuals who regularly consume Yerba Mate, it can be an important source of polyunsaturated fatty acids (PUFA) supplementation. The most preferred way to brew the tea is cold infusion, which delivers the highest dose of unchanged PUFAs. This method of brewing also reduces the gastrointestinal exposure to high temperature, and thus reduces the risk of cancer incidence.

Keywords


alpha-linolenic acid; linoleic acid; Yerba Mate; omega 3, omega 6

Full Text:

PDF

References


Heck C.I., Mejia E.G.: Yerba Mate tea (Ilex pagaguariensis): A comprehensive review on chemistry, health implications, and technological considerations. J Food Sci. 2007, 7, 138–151.

Filip R., Ferrano G.E.: Researching on new species of “Mate”: Ilex breicuspis: phytochemical and pharmacology study. Eur J Nutr. 2003, 42, 50–54.

Gonzalez A., Ferreira F., Vazguez A., Moyna P., Paz E.A.: Biological screeninig of Uruguayan medicanal – plants. J Ethnopharmacol. 1993, 39, 217–220.

Schinella G., Fantinelli J.C., Mosca S.M.: Cardioprotective effects of Ilex paraguariensis extract: evidence for a nitric oxide – dependent mechanism. Clin Nutr. 2005, 24, 360–366.

Filip R., Lotito S.B., Ferraro G., Fraga C.G.: Antioxidant of Ilex paraguariensis and related species. Nutr Res. 2000, 20, 1437–1446.

Ramirez-Mares M.V., Chandra S., De Mejia E.G.: In vitro chemopreventive activity of Camellia sinensis, Ilex paraguariensis and Ardisiacompressa tea extracts and selected polyphenols. Mutat Res. 2004, 554, 53–64.

López D., García-Maroto F.: Plants as ‘chemical factories’ for the production of polyunsaturated fatty acid. Biotechnol Adv. 2000, 18, 481–497.

Calder P.: Omega-3 fatty acids and inflammatory processes. Nutrients. 2010, 2, 355–374.

Walczewska A., Stępien T., Bewicz-Binkowska D., Zgórzyńska E.: The role of docosahexaenoic acid in neuronal function. Postępy Hig Med Dośw. 2011, 65, 314–327.

James M.J., Gibson R.A., Cleland L.G.: Dietary polyunsaturated fatty acids and inflammatory mediator production. Am J Clin Nutr. 2000, 71, 343.

Khanapure S.P., Garvey D.S., Janero D.R., Letts L.G.: Eicosanoids in inflammation: biosynthesis, pharmacology, and therapeutic frontiers. Curr Top Med Chem. 2007, 7, 311–340.

Bozza P.T., Bakker-Abreu I., Navarro-Xavier R.A., Bandeira-Melo C.: Lipid body function in eicosanoid synthesis: an update. Prostaglandies Leukot Essent Fatty Acids. 2011, 85, 205–213.

Folch J., Lees M., Sloane G.H.: A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem. 1957, 226, 497–509.

Russo G.L.: Dietary n-6 and n-3 polyunsaturated fatty acids: From biochemistry to clinical implications in cardiovascularn prevention. Biochem Pharmacol. 2009, 77, 937–946.

Bresson J.L., Flynn A., Heinonen M., Hulshof K.: Reference intake values for n-3 and n-6 polyunsaturated fatty acids. EFSA J. 2009, 1176, 1–12.

Elmadfa I., Freising H., Novak V., Hofstädter D., Hasenegger V., Ferge M.: Österreichischer Ernährungsbericht. Auflage, Wien 2008, 1.

Astorg P., Arnault N., Czernichow S. et al.: Intake levels and food sources for the principal n-6 and n-3 polyunsaturated fatty acids of the adult population in France. Cahiers de Nutrition et de Diététique. 2005, 40, 260–269.

The National FINDIET 2007 Survey. Report B23/2008. Eds: M. Paturi, H. Tapanainen, H. Reinivuo, P. Pietinen. KTL-National Public Health Institute, Helsinki 2008.

Kruizinga A.G., Westenbrink S., Bosch L.M.C. et al.: De inneming van Omega-3 and-6 vetzuren en van vitamines A, D en E bijjongvolwassenen. Aanvullende berekeningen op basis van Voedselconsumptiepeiling 2003. TNO rapport V7451. Zeist: TNO KvL. 2007.

Becker W., Pearson M.: Riksmaten 1997–1998. Befolkningenskostvanoroch näringsintag. Metod-ochresultatanalys. Livsmedelsverket, Uppsala 2002.

Simopoulos A.P.: The importance of the omega-6⁄omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp Biol Med. 2008, 233, 674–688.

Loria D., Barrios E., Zanetti R.: Cancer and yerba mate consumption: a review of possible associations. Rev Panam Salud Publica. 2009, 25, 530–539.

Maskan M., Karatas S.: Fatty acid oxidation of pistachio nuts stored under various atmospheric conditions and different temperatures. J Sci Food Agric. 1998, 77, 334–340.




DOI: https://doi.org/10.21164/pomjlifesci.59

Copyright (c) 2016 Dominika Maciejewska, Agnieszka Łukomska, Karolina Jakubczyk, Irena Baranowska-Bosiacka, Ewa Stachowska, Dariusz Chlubek, Izabela Gutowska

License URL: https://creativecommons.org/licenses/by-nc-nd/3.0/pl/